These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 25028567

  • 1. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
    Kawaguchi-Suzuki M, Frye RF, Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Markowitz JS.
    Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
    [Abstract] [Full Text] [Related]

  • 2. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.
    Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah A.
    Clin Pharmacol Ther; 2004 Nov; 76(5):428-40. PubMed ID: 15536458
    [Abstract] [Full Text] [Related]

  • 3. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
    Albassam AA, Frye RF, Markowitz JS.
    Chem Biol Interact; 2017 Jun 01; 271():24-29. PubMed ID: 28457856
    [Abstract] [Full Text] [Related]

  • 4. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
    Brantley SJ, Oberlies NH, Kroll DJ, Paine MF.
    J Pharmacol Exp Ther; 2010 Mar 01; 332(3):1081-7. PubMed ID: 19934397
    [Abstract] [Full Text] [Related]

  • 5. An ex vivo approach to botanical-drug interactions: a proof of concept study.
    Wang X, Zhu HJ, Munoz J, Gurley BJ, Markowitz JS.
    J Ethnopharmacol; 2015 Apr 02; 163():149-56. PubMed ID: 25623616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS.
    Drug Metab Dispos; 2013 Sep 02; 41(9):1679-85. PubMed ID: 23835761
    [Abstract] [Full Text] [Related]

  • 8. The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.
    Mooiman KD, Goey AK, Huijbregts TJ, Maas-Bakker RF, Beijnen JH, Schellens JH, Meijerman I.
    J Pharm Pharmacol; 2014 Sep 02; 66(9):1339-46. PubMed ID: 24730468
    [Abstract] [Full Text] [Related]

  • 9. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
    Davis-Searles PR, Nakanishi Y, Kim NC, Graf TN, Oberlies NH, Wani MC, Wall ME, Agarwal R, Kroll DJ.
    Cancer Res; 2005 May 15; 65(10):4448-57. PubMed ID: 15899838
    [Abstract] [Full Text] [Related]

  • 10. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
    Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD.
    Clin Pharmacol Ther; 2004 Jan 15; 75(1):89-100. PubMed ID: 14749695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS, Black SR, Patel PR, So J, Mathews JM.
    Planta Med; 2007 Jul 15; 73(8):731-41. PubMed ID: 17611934
    [Abstract] [Full Text] [Related]

  • 13. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.
    van Erp NP, Baker SD, Zhao M, Rudek MA, Guchelaar HJ, Nortier JW, Sparreboom A, Gelderblom H.
    Clin Cancer Res; 2005 Nov 01; 11(21):7800-6. PubMed ID: 16278402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.
    Clin Pharmacol Ther; 2001 Oct 01; 70(4):317-26. PubMed ID: 11673747
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.
    Liu J, Banuvar S, Viana M, Barengolts E, Chen SN, Pauli GF, van Breemen RB.
    Drug Metab Dispos; 2023 Feb 01; 51(2):199-204. PubMed ID: 36328482
    [Abstract] [Full Text] [Related]

  • 17. Determination of Flavonolignan Compositional Ratios in Silybum marianum (Milk Thistle) Extracts Using High-Performance Liquid Chromatography.
    Chen W, Zhao X, Huang Z, Luo S, Zhang X, Sun W, Lan T, He R.
    Molecules; 2024 Jun 21; 29(13):. PubMed ID: 38998902
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M, Bekersky I, Blum RA, Tolbert D.
    Pharmacotherapy; 2012 Apr 21; 32(4):340-53. PubMed ID: 22422635
    [Abstract] [Full Text] [Related]

  • 19. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle.
    Althagafy HS, Graf TN, Sy-Cordero AA, Gufford BT, Paine MF, Wagoner J, Polyak SJ, Croatt MP, Oberlies NH.
    Bioorg Med Chem; 2013 Jul 01; 21(13):3919-26. PubMed ID: 23673225
    [Abstract] [Full Text] [Related]

  • 20. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes.
    Faisal Z, Mohos V, Fliszár-Nyúl E, Valentová K, Káňová K, Lemli B, Kunsági-Máté S, Poór M.
    Biomed Pharmacother; 2021 Jun 01; 138():111459. PubMed ID: 33706132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.